ABOUT
Overview
Management
Drug Development Team
Board of Directors
Corporate Partnerships
SCIENCE
Technology Platform
Scientific Publications
PIPELINE
Overview
Piclidenoson (CF101)
Namodenoson (CF102)
CF602
Cannabinoids
INVESTORS
Overview
News & Events
Company Information
Financial Information
Stock Information
SEC Fillings
Corporate Governance
Shareholders Meetings
CONTACT
Menu
×
Events Calendar
Investors
Investors
Overview
News & Events
Overview
Press Releases
In The News
Research
Events Calendar
Presentations
Email Alerts
Company Info
Overview
Video
Management
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Section 16 Filings
Governance
Overview
Board of Directors
Governance Documents
Shareholders Meetings
Update on Phase III Psoriasis Study
Oct 15, 2020 4:15 pm EDT
Audio
Webcast
Email Alerts
Contacts
RSS News Feed
